Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.9100
-0.0400 (-4.21%)
At close: May 26, 2026, 4:00 PM EDT
0.8901
-0.0199 (-2.19%)
After-hours: May 26, 2026, 6:36 PM EDT

Aprea Therapeutics Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Aprea Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $4.30. The average 1-year stock price forecast is 372.53% higher than the current stock price, while the lowest is $1.20 (+31.87%) and the highest is $6.00 (+559.34%).

Price Target: $4.30 (+372.53%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$1.20$4.30$5.00$6.00
Change+31.87%+372.53%+449.45%+559.34%

Analyst Ratings

The average analyst rating for Aprea Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingDec '25Jan '26Feb '26Mar '26Apr '26May '26
Strong Buy222223
Buy111111
Hold000000
Sell000000
Strong Sell000000
Total333334

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Maxim Group
Maxim Group
Buy
Reiterates
$10$5
BuyReiterates$10$5+449.45%May 14, 2026
Wedbush
Wedbush
Buy
Reiterates
$7$6
BuyReiterates$7$6+559.34%May 14, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Maintains
$4$1.2
BuyMaintains$4$1.2+31.87%Mar 31, 2026

Financial Forecast

Revenue This Year
727.60K
from 285.76K
Increased by 154.62%
Revenue Next Year
1.54M
from 727.60K
Increased by 111.52%
EPS This Year
-0.78
from -1.93
EPS Next Year
-0.71
from -0.78
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
--583.23K1.50M285.76K727.60K1.54M
Revenue Growth
---157.63%-80.98%154.62%111.52%
EPS
-34.88-67.99-3.95-2.35-1.93-0.78-0.71
EPS Growth
-------
Forward PE
-------
No. Analysts
-----66
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20262027202820292030203120322033
High2.2M4.8M
Avg727,5971.5M
Lown/an/a

Revenue Growth

Revenue Growth20262027202820292030203120322033
High
686.3%
553.1%
Avg
154.6%
111.5%
Low--

EPS Forecast

EPS20262027202820292030
High-0.55-0.44
Avg-0.78-0.71
Low-0.93-1.03

EPS Growth

EPS Growth20262027202820292030
High--
Avg--
Low--
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.